Venus Remedies Limited (VENUSREM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.136x

Based on the latest financial reports, Venus Remedies Limited (VENUSREM) has a cash flow conversion efficiency ratio of 0.136x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs811.10 Million ≈ $8.77 Million USD) by net assets (Rs5.94 Billion ≈ $64.27 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see how much is Venus Remedies Limited worth for the company's overall valuation and market capitalisation.

Venus Remedies Limited - Cash Flow Conversion Efficiency Trend (2006–2025)

This chart illustrates how Venus Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Venus Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Venus Remedies Limited ranked by their cash flow conversion efficiency. Explore Venus Remedies Limited (VENUSREM) cash flow quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Ard Grup Bilisim Teknolojileri AS
IS:ARDYZ
0.044x
Torrid Holdings Inc
NYSE:CURV
-0.053x
Advanced Information Technology Public Company Limited
BK:AIT
0.184x
Natures Sunshine Products Inc
NASDAQ:NATR
0.005x
Hocheng Corp
TW:1810
-0.001x
Stellus Capital Investment
NYSE:SCM
154752.995x
AC IMMUNE SA SF-02
F:IMR
-0.469x
Cint Group AB
ST:CINT
0.036x

Annual Cash Flow Conversion Efficiency for Venus Remedies Limited (2006–2025)

The table below shows the annual cash flow conversion efficiency of Venus Remedies Limited from 2006 to 2025. View VENUSREM share price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs5.61 Billion
≈ $60.66 Million
Rs909.20 Million
≈ $9.83 Million
0.162x +111.94%
2024-03-31 Rs4.88 Billion
≈ $52.73 Million
Rs372.85 Million
≈ $4.03 Million
0.076x -3.87%
2023-03-31 Rs4.60 Billion
≈ $49.78 Million
Rs366.20 Million
≈ $3.96 Million
0.080x -14.55%
2022-03-31 Rs4.40 Billion
≈ $47.63 Million
Rs410.01 Million
≈ $4.43 Million
0.093x -71.90%
2021-03-31 Rs4.00 Billion
≈ $43.29 Million
Rs1.33 Billion
≈ $14.34 Million
0.331x +39.12%
2020-03-31 Rs3.23 Billion
≈ $34.97 Million
Rs770.10 Million
≈ $8.33 Million
0.238x +74.71%
2019-03-31 Rs3.33 Billion
≈ $35.96 Million
Rs453.27 Million
≈ $4.90 Million
0.136x -4.09%
2018-03-31 Rs3.62 Billion
≈ $39.14 Million
Rs514.36 Million
≈ $5.56 Million
0.142x -35.64%
2017-03-31 Rs4.52 Billion
≈ $48.84 Million
Rs997.24 Million
≈ $10.78 Million
0.221x +106.13%
2016-03-31 Rs4.38 Billion
≈ $47.33 Million
Rs468.81 Million
≈ $5.07 Million
0.107x -27.85%
2015-03-31 Rs4.57 Billion
≈ $49.39 Million
Rs678.05 Million
≈ $7.33 Million
0.148x +30.18%
2014-03-31 Rs4.62 Billion
≈ $49.92 Million
Rs526.46 Million
≈ $5.69 Million
0.114x -17.09%
2013-03-31 Rs3.79 Billion
≈ $41.00 Million
Rs521.50 Million
≈ $5.64 Million
0.138x +1.44%
2012-03-31 Rs3.07 Billion
≈ $33.23 Million
Rs416.70 Million
≈ $4.51 Million
0.136x -13.98%
2011-03-31 Rs2.37 Billion
≈ $25.62 Million
Rs373.47 Million
≈ $4.04 Million
0.158x -14.83%
2010-03-31 Rs1.71 Billion
≈ $18.51 Million
Rs316.83 Million
≈ $3.43 Million
0.185x +35.37%
2009-03-31 Rs1.39 Billion
≈ $14.99 Million
Rs189.50 Million
≈ $2.05 Million
0.137x -36.02%
2008-03-31 Rs889.86 Million
≈ $9.62 Million
Rs190.17 Million
≈ $2.06 Million
0.214x -50.89%
2007-03-31 Rs551.31 Million
≈ $5.96 Million
Rs239.88 Million
≈ $2.59 Million
0.435x +58.20%
2006-03-31 Rs318.96 Million
≈ $3.45 Million
Rs87.73 Million
≈ $948.76K
0.275x --

About Venus Remedies Limited

NSE:VENUSREM India Drug Manufacturers - Specialty & Generic
Market Cap
$228.72 Million
Rs21.15 Billion INR
Market Cap Rank
#16124 Global
#823 in India
Share Price
Rs1582.20
Change (1 day)
+2.09%
52-Week Range
Rs432.30 - Rs1947.00
All Time High
Rs1947.00
About

Venus Remedies Limited engages in the pharmaceutical business in India and internationally. It is involved in the research and development of solutions focusing on antimicrobial resistance and oncology. The company also offers analgesic, analgesic and antipyretic, antibiotic, anticoagulant, antiemetic, antiviral, cardiovascular, disinfectant and antiseptic, gastro therapy, hepatoprotective, hormo… Read more